• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

智能自动化药物管理和治疗:医疗保健的未来。

Intelligent automated drug administration and therapy: future of healthcare.

机构信息

Centre for Biomedical Engineering, Indian Institute of Technology, Delhi, New Delhi, India.

Renaissance Technology Private Ltd Delhi, New Delhi, India.

出版信息

Drug Deliv Transl Res. 2021 Oct;11(5):1878-1902. doi: 10.1007/s13346-020-00876-4. Epub 2021 Jan 14.

DOI:10.1007/s13346-020-00876-4
PMID:33447941
Abstract

In the twenty-first century, the collaboration of control engineering and the healthcare sector has matured to some extent; however, the future will have promising opportunities, vast applications, and some challenges. Due to advancements in processing speed, the closed-loop administration of drugs has gained popularity for critically ill patients in intensive care units and routine life such as personalized drug delivery or implantable therapeutic devices. For developing a closed-loop drug delivery system, the control system works with a group of technologies like sensors, micromachining, wireless technologies, and pharmaceuticals. Recently, the integration of artificial intelligence techniques such as fuzzy logic, neural network, and reinforcement learning with the closed-loop drug delivery systems has brought their applications closer to fully intelligent automatic healthcare systems. This review's main objectives are to discuss the current developments, possibilities, and future visions in closed-loop drug delivery systems, for providing treatment to patients suffering from chronic diseases. It summarizes the present insight of closed-loop drug delivery/therapy for diabetes, gastrointestinal tract disease, cancer, anesthesia administration, cardiac ailments, and neurological disorders, from a perspective to show the research in the area of control theory.

摘要

在二十一世纪,控制工程与医疗保健领域的合作已经发展到一定程度;然而,未来将有广阔的应用前景和一些挑战。由于处理速度的提高,闭环药物管理在重症监护病房和常规生活中(如个性化药物输送或植入式治疗装置)受到了重症患者的欢迎。为了开发闭环药物输送系统,控制系统与一组技术(如传感器、微加工、无线技术和药物)协同工作。最近,人工智能技术(如模糊逻辑、神经网络和强化学习)与闭环药物输送系统的集成,使它们的应用更接近完全智能的自动医疗保健系统。这篇综述的主要目的是讨论闭环药物输送系统在为慢性疾病患者提供治疗方面的最新进展、可能性和未来愿景。它从控制理论的角度总结了闭环药物输送/治疗糖尿病、胃肠道疾病、癌症、麻醉管理、心脏疾病和神经紊乱的最新见解,以展示该领域的研究情况。

相似文献

1
Intelligent automated drug administration and therapy: future of healthcare.智能自动化药物管理和治疗:医疗保健的未来。
Drug Deliv Transl Res. 2021 Oct;11(5):1878-1902. doi: 10.1007/s13346-020-00876-4. Epub 2021 Jan 14.
2
DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.DREAM5:一项开放标签、随机、交叉研究,旨在评估在 1 型糖尿病患者家中使用 MD-Logic 自动化胰岛素输送系统与传感器增强型泵治疗进行日夜闭环控制的安全性和有效性。
Diabetes Obes Metab. 2019 Apr;21(4):822-828. doi: 10.1111/dom.13585. Epub 2018 Dec 21.
3
Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes.基于数据驱动的血糖动力学建模与预测:机器学习在 1 型糖尿病中的应用。
Artif Intell Med. 2019 Jul;98:109-134. doi: 10.1016/j.artmed.2019.07.007. Epub 2019 Jul 26.
4
Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?智能胰岛素与 1 型糖尿病的人工智能:真正的胜者会站起来吗?
Int J Mol Sci. 2023 Aug 24;24(17):13139. doi: 10.3390/ijms241713139.
5
[Closed-loop systems - Update 2020].[闭环系统 - 2020年更新]
Ther Umsch. 2020 Sep;77(7):312-318. doi: 10.1024/0040-5930/a001197.
6
The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.“Glucositter” 1 型糖尿病夜间自动化闭环系统:一项随机交叉试验。
Pediatr Diabetes. 2013 May;14(3):159-67. doi: 10.1111/pedi.12025. Epub 2013 Feb 28.
7
Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.葡萄糖反应性胰岛素和胰高血糖素递送(双激素人工胰腺)在 1 型糖尿病成人中的随机交叉对照试验。
CMAJ. 2013 Mar 5;185(4):297-305. doi: 10.1503/cmaj.121265. Epub 2013 Jan 28.
8
Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.使用人工胰腺对1型糖尿病儿科患者进行全自动闭环胰岛素输注与半自动混合控制的比较
Diabetes Care. 2008 May;31(5):934-9. doi: 10.2337/dc07-1967. Epub 2008 Feb 5.
9
[What is the current state of the artificial pancreas in diabetes care?].[糖尿病护理中人工胰腺的当前状况如何?]
Internist (Berl). 2020 Jan;61(1):102-109. doi: 10.1007/s00108-019-00713-y.
10
Behavioural implications of traditional treatment and closed-loop automated insulin delivery systems in Type 1 diabetes: applying a cognitive restraint theory framework.1 型糖尿病中传统治疗和闭环自动化胰岛素输送系统的行为学影响:应用认知约束理论框架。
Diabet Med. 2017 Nov;34(11):1500-1507. doi: 10.1111/dme.13407. Epub 2017 Sep 11.

引用本文的文献

1
Polymerase Chain Reaction Chips for Biomarker Discovery and Validation in Drug Development.用于药物开发中生物标志物发现与验证的聚合酶链反应芯片
Micromachines (Basel). 2025 Feb 20;16(3):243. doi: 10.3390/mi16030243.
2
Advances in Wearable Biosensors for Wound Healing and Infection Monitoring.用于伤口愈合和感染监测的可穿戴生物传感器的进展
Biosensors (Basel). 2025 Feb 23;15(3):139. doi: 10.3390/bios15030139.
3
Design research on a smart infusion device to reduce medical workload and enhance patient safety.一款用于减轻医疗工作量并提高患者安全性的智能输液设备的设计研究。

本文引用的文献

1
Optimal sliding mode control of drug delivery in cancerous tumour chemotherapy considering the obesity effects.考虑肥胖影响的癌性肿瘤化疗中药物递送的最优滑模控制
IET Syst Biol. 2018 Aug;12(4):185-189. doi: 10.1049/iet-syb.2017.0094.
2
Autonomous Systems in Anesthesia: Where Do We Stand in 2020? A Narrative Review.麻醉中的自主系统:2020 年我们处于什么位置?一篇叙述性综述。
Anesth Analg. 2020 May;130(5):1120-1132. doi: 10.1213/ANE.0000000000004646.
3
Glucose outcomes of a learning-type artificial pancreas with an unannounced meal in type 1 diabetes.
Sci Rep. 2025 Mar 18;15(1):9265. doi: 10.1038/s41598-025-93911-8.
4
State-of-the-art anesthesia practices: a comprehensive review on optimizing patient safety and recovery.最新的麻醉实践:关于优化患者安全与恢复的全面综述
BMC Surg. 2025 Jan 20;25(1):32. doi: 10.1186/s12893-025-02763-6.
5
Etodolac utility in osteoarthritis: drug delivery challenges, topical nanotherapeutic strategies and potential synergies.依托度酸在骨关节炎中的应用:药物传递挑战、局部纳米治疗策略及潜在协同作用。
Ther Deliv. 2024;15(12):977-995. doi: 10.1080/20415990.2024.2405456. Epub 2024 Sep 30.
6
Artificial Intelligence's Impact on Drug Discovery and Development From Bench to Bedside.人工智能对从实验室到临床的药物发现与开发的影响
Cureus. 2023 Oct 22;15(10):e47486. doi: 10.7759/cureus.47486. eCollection 2023 Oct.
7
Electroactive Polymers for On-Demand Drug Release.用于按需药物释放的电活性聚合物。
Adv Healthc Mater. 2024 Jan;13(3):e2301759. doi: 10.1002/adhm.202301759. Epub 2023 Nov 12.
8
Systemic inflammation as a biomarker of seizure propensity and a target for treatment to reduce seizure propensity.全身性炎症作为癫痫倾向的生物标志物和治疗靶点以降低癫痫倾向。
Epilepsia Open. 2023 Mar;8(1):221-234. doi: 10.1002/epi4.12684. Epub 2023 Jan 23.
9
Translational Bioinformatics to Enable Precision Medicine for All: Elevating Equity across Molecular, Clinical, and Digital Realms.实现人人受益的精准医学的转化生物信息学:在分子、临床和数字领域提升公平性。
Yearb Med Inform. 2022 Aug;31(1):106-115. doi: 10.1055/s-0042-1742513. Epub 2022 Dec 4.
10
Electrochemical Microneedles: Innovative Instruments in Health Care.电化学微针:医疗保健领域的创新器械。
Biosensors (Basel). 2022 Sep 28;12(10):801. doi: 10.3390/bios12100801.
1 型糖尿病中未预告餐时学习型人工胰腺的血糖结局。
Comput Methods Programs Biomed. 2020 Jul;191:105416. doi: 10.1016/j.cmpb.2020.105416. Epub 2020 Feb 26.
4
The combined effect of optimal control and swarm intelligence on optimization of cancer chemotherapy.最优控制和群体智能对癌症化疗优化的综合影响。
Comput Methods Programs Biomed. 2020 Jun;189:105327. doi: 10.1016/j.cmpb.2020.105327. Epub 2020 Jan 9.
5
Blood glucose concentration control for type 1 diabetic patients: a multiple-model strategy.1 型糖尿病患者的血糖浓度控制:一种多模型策略。
IET Syst Biol. 2020 Feb;14(1):24-30. doi: 10.1049/iet-syb.2018.5049.
6
An optimal interval type-2 fuzzy logic control based closed-loop drug administration to regulate the mean arterial blood pressure.基于最优区间型 2 模糊逻辑控制的闭环给药调节平均动脉血压。
Comput Methods Programs Biomed. 2020 Mar;185:105167. doi: 10.1016/j.cmpb.2019.105167. Epub 2019 Oct 31.
7
Neural stimulation systems for the control of refractory epilepsy: a review.用于难治性癫痫控制的神经刺激系统:综述。
J Neuroeng Rehabil. 2019 Oct 29;16(1):126. doi: 10.1186/s12984-019-0605-x.
8
Real-time artificial intelligence for detection of upper gastrointestinal cancer by endoscopy: a multicentre, case-control, diagnostic study.实时人工智能用于内窥镜检查上消化道癌的检测:一项多中心、病例对照、诊断研究。
Lancet Oncol. 2019 Dec;20(12):1645-1654. doi: 10.1016/S1470-2045(19)30637-0. Epub 2019 Oct 4.
9
Novel Single-Site Device for Conjoined Glucose Sensing and Insulin Infusion: Performance Evaluation in Diabetes Patients During Home-Use.新型单点连接葡萄糖感应与胰岛素输注装置:家庭使用期间糖尿病患者的性能评估。
IEEE Trans Biomed Eng. 2020 Jan;67(1):323-332. doi: 10.1109/TBME.2019.2925434. Epub 2019 Jun 27.
10
Derivation of an optimal trajectory and nonlinear adaptive controller design for drug delivery in cancerous tumor chemotherapy.癌症肿瘤化疗中药物输送的最优轨迹推导和非线性自适应控制器设计
Comput Biol Med. 2019 Jun;109:195-206. doi: 10.1016/j.compbiomed.2019.04.011. Epub 2019 Apr 19.